Video from AACC: Fluxergy's multimodal testing platform Fluxergy president and co-founder Tej Patel sat down with us at AACC 2022 and discussed the company’s multimodal, multiomic platform that enables doctors to perform different kinds of tests, including reverse transcription polymerase chain reaction and serology tests, using a single instrument and software program.Read More
Video from AACC: PerkinElmer on diagnostics, acquisitions Greg Stock, general manager of PerkinElmer’s Euroimmun business, discussed products and technologies on display at AACC 2022, as well as the integration of acquired companies such as Oxford Immunotec.Read More
Video from AACC: Enzo BioChem CEO on COVID-19 test landscape Enzo BioChem develops diagnostic tests and provides testing in centers throughout New York and its surrounding areas. CEO Hamid Erfanian spoke to us at AACC 2022 about the changes he sees in the in vitro diagnostics landscape as the COVID-19 pandemic evolves.Read More
Video from AACC: AACC president on Theranos, VALID Act Dr. Stephen Master, president of the American Association for Clinical Chemistry, provided his thoughts about the main highlights of the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo held this week in Chicago.Read More
Video from AACC: Siemens Healthineers’ NAFLD test Siemens Healthineers CMO Charles Cooper spoke to LabPulse.com (sister site of ScienceBoard.net) about the firm’s Enhanced Liver Fibrosis blood test and how it can be used to assess the risk of nonalcoholic fatty liver disease (NAFLD) progression and liver-related events.Read More
Video from AACC: Thermo Fisher CMO on the future of diagnostics Thermo Fisher Scientific featured a broad array of diagnostic testing products at AACC 2022. Chief Medical Officer (CMO) Manoj Gandhi caught up with ScienceBoard.net's sister site LabPulse.com to discuss shifts in the diagnostic testing landscape.Read More
Studies uncover findings on antibody responses, immunity Findings from two studies add to a growing body of knowledge that is essential for guiding public health initiatives and might one day enable clinicians to assess individuals’ immunity to SARS-CoV-2, according to AACC.Read More